🇺🇸 CYTK — Cytokinetics, Incorporated

Salud Compra
← Volver

Precio actual

53,69 USD

Máx. histórico

108,06

1033 días

Split 1:6 del 25/06/2013

Caída desde máximo

-50,31%

Rango 52 semanas

53,55 – 88,31

Variación hoy

-3,35%

Cierre anterior

55,55

Rango de hoy

53,55 – 56,51

Volumen hoy

2.560.975

Peor caída histórica

-97,06%

05/05/2004 → 10/10/2014

Recuperado en 3377 días

Volatilidad anualizada ⓘ

69,41%

Información
Nombre completo
Cytokinetics, Incorporated
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
673
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,39 USD (puede no estar actualizado)
Primera cotización
30/04/2004
Precio actualizado
hace 5 horas
Sobre la empresa

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.

Splits Registrados en el histórico de precios
Fecha Ratio
25/06/2013 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
21/04/2017 13,60 14,35 13,40 14,25 +5,17% 6,99% 6.550.400
20/04/2017 13,25 13,70 13,20 13,55 +2,81% 3,77% 944.500
19/04/2017 13,00 13,40 12,80 13,18 +1,78% 4,62% 1.095.700
18/04/2017 12,60 13,40 12,60 12,95 +10,21% 6,35% 1.500.500
17/04/2017 11,65 11,80 11,55 11,75 +1,29% 2,15% 194.000
13/04/2017 11,55 11,85 11,55 11,60 -0,85% 2,60% 174.800
12/04/2017 11,40 11,75 11,20 11,70 +2,63% 4,82% 317.100
11/04/2017 11,25 11,50 11,03 11,40 +0,88% 4,18% 235.300
10/04/2017 11,45 11,66 11,25 11,30 -1,14% 3,58% 219.100
07/04/2017 11,40 11,50 11,20 11,43 -0,17% 2,63% 308.000
06/04/2017 11,20 11,45 11,00 11,45 +2,23% 4,02% 289.400
05/04/2017 11,85 12,15 11,00 11,20 -5,08% 9,70% 501.400
04/04/2017 12,40 12,40 11,60 11,80 -5,22% 6,45% 450.200
03/04/2017 13,05 13,05 12,40 12,45 -3,11% 4,98% 235.300
31/03/2017 12,85 13,00 12,70 12,85 +0,39% 2,33% 294.800
30/03/2017 12,60 13,00 12,50 12,80 +1,99% 3,97% 437.700
29/03/2017 12,55 12,80 12,43 12,55 +0,40% 2,95% 323.000
28/03/2017 12,65 12,86 12,45 12,50 -1,57% 3,24% 298.800
27/03/2017 12,45 12,73 12,40 12,70 +0,79% 2,65% 446.100
24/03/2017 12,60 13,20 12,50 12,60 +0,40% 5,56% 413.100
23/03/2017 12,75 13,00 12,45 12,55 -1,95% 4,31% 281.000
22/03/2017 12,25 12,85 12,20 12,80 +4,92% 5,31% 422.000
21/03/2017 12,55 12,68 11,80 12,20 -2,40% 7,01% 438.100
20/03/2017 12,45 12,60 12,23 12,50 +0,81% 2,97% 365.400
17/03/2017 13,20 13,45 12,15 12,40 -7,12% 9,85% 878.800
16/03/2017 13,65 13,70 13,25 13,35 -2,20% 3,30% 278.400
15/03/2017 13,10 13,70 12,95 13,65 +5,00% 5,73% 685.500
14/03/2017 12,85 13,05 12,40 13,00 +0,00% 5,06% 258.600
13/03/2017 13,05 13,15 12,81 13,00 +0,00% 2,61% 343.200
10/03/2017 13,00 13,20 12,75 13,00 +0,78% 3,46% 477.300